PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 28137980-1 2017 The HIV protease inhibitor Nelfinavir (NFV) inhibits PI3K/AKT and MAPK/ERK signaling pathways, emerging targets in thyroid cancers. Nelfinavir 27-37 AKT serine/threonine kinase 1 Homo sapiens 58-61 28137980-10 2017 NFV (20 microM) decreased the levels of total and p-AKT in PTEN-deficient FTC133 cells. Nelfinavir 0-3 AKT serine/threonine kinase 1 Homo sapiens 52-55